These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 9416898

  • 41. Spatial features in body-surface potential maps can identify patients with a history of sustained ventricular tachycardia.
    Hubley-Kozey CL, Mitchell LB, Gardner MJ, Warren JW, Penney CJ, Smith ER, Horácek BM.
    Circulation; 1995 Oct 01; 92(7):1825-38. PubMed ID: 7671367
    [Abstract] [Full Text] [Related]

  • 42. The use of fontaine leads in the diagnosis of arrhythmogenic right ventricular dysplasia.
    Gottschalk B, Gysel M, Barbosa-Barros R, De Sousa Rocha RP, Pérez-Riera AR, Zhang L, Fontaine G, Baranchuk A.
    Ann Noninvasive Electrocardiol; 2014 May 01; 19(3):279-84. PubMed ID: 24597934
    [Abstract] [Full Text] [Related]

  • 43. New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Cox MG, van der Smagt JJ, Wilde AA, Wiesfeld AC, Atsma DE, Nelen MR, Rodriguez LM, Loh P, Cramer MJ, Doevendans PA, van Tintelen JP, de Bakker JM, Hauer RN.
    Circ Arrhythm Electrophysiol; 2009 Oct 01; 2(5):524-30. PubMed ID: 19843920
    [Abstract] [Full Text] [Related]

  • 44. Value of a novel 16-lead High-Definition ECG machine to detect conduction abnormalities in structural heart disease.
    Li GL, Saguner AM, Akdis D, Fontaine GH.
    Pacing Clin Electrophysiol; 2018 Jun 01; 41(6):643-655. PubMed ID: 29603270
    [Abstract] [Full Text] [Related]

  • 45. Mapping of body surface potentials in patients with the idiopathic long QT syndrome.
    De Ambroggi L, Bertoni T, Locati E, Stramba-Badiale M, Schwartz PJ.
    Circulation; 1986 Dec 01; 74(6):1334-45. PubMed ID: 3779919
    [Abstract] [Full Text] [Related]

  • 46. Genetics of myocarditis in arrhythmogenic right ventricular dysplasia.
    Lopez-Ayala JM, Pastor-Quirante F, Gonzalez-Carrillo J, Lopez-Cuenca D, Sanchez-Munoz JJ, Oliva-Sandoval MJ, Gimeno JR.
    Heart Rhythm; 2015 Apr 01; 12(4):766-73. PubMed ID: 25616123
    [Abstract] [Full Text] [Related]

  • 47. Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardias.
    Müssigbrodt A, Knopp H, Efimova E, Weber A, Bertagnolli L, Hilbert S, Kosiuk J, Dinov B, Bode K, Kircher S, Dagres N, Richter S, Sommer P, Husser D, Bollmann A, Hindricks G, Arya A.
    Europace; 2018 Jul 01; 20(7):1182-1187. PubMed ID: 28595345
    [Abstract] [Full Text] [Related]

  • 48. The utility of quantitative body surface isoarea mapping for predicting ventricular tachyarrhythmias.
    Goldner BG, Horwitz L, Kohn N, Lesser M, Ehrlich J, Cohen TJ, Jadonath R.
    Pacing Clin Electrophysiol; 1999 Mar 01; 22(3):453-61. PubMed ID: 10192854
    [Abstract] [Full Text] [Related]

  • 49. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G, Corrado D, Delise P, Fedele F, Gaita F, Gentile F, Giustetto C, Michelucci A, Padeletti L, Priori S.
    G Ital Cardiol (Rome); 2010 Nov 01; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [Abstract] [Full Text] [Related]

  • 50. The S-wave angle identifies arrhythmogenic right ventricular cardiomyopathy in patients with electrocardiographically concealed disease phenotype.
    Cortez D, Svensson A, Carlson J, Graw S, Sharma N, Brun F, Spezzacatene A, Mestroni L, Platonov PG.
    J Electrocardiol; 2018 Nov 01; 51(6):1003-1008. PubMed ID: 30497719
    [Abstract] [Full Text] [Related]

  • 51. [Electrocardiographic findings in arrhythmogenic right ventricular dysplasia (ARVD) evaluated by body surface mapping].
    Okano Y.
    Nihon Rinsho; 1995 Jan 01; 53(1):230-8. PubMed ID: 7897849
    [Abstract] [Full Text] [Related]

  • 52. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria.
    Nasir K, Bomma C, Tandri H, Roguin A, Dalal D, Prakasa K, Tichnell C, James C, Spevak PJ, Marcus F, Calkins H.
    Circulation; 2004 Sep 21; 110(12):1527-34. PubMed ID: 15381658
    [Abstract] [Full Text] [Related]

  • 53. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: an electrocardiogram-based review.
    Nunes de Alencar Neto J, Baranchuk A, Bayés-Genís A, Bayés de Luna A.
    Europace; 2018 Jun 01; 20(FI1):f3-f12. PubMed ID: 29272363
    [Abstract] [Full Text] [Related]

  • 54. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE.
    Circulation; 2009 Aug 04; 120(5):366-75. PubMed ID: 19620503
    [Abstract] [Full Text] [Related]

  • 55. Symptomatic arrhythmogenic right ventricular dysplasia/cardiomyopathy. A two-centre retrospective study of 15 symptomatic ARVD/C cases and focus on the diagnostic value of MRI in symptomatic ARVD/C patients.
    Dewilde W, Boersma L, Delanote J, Pollet P, Scholzel B, Wever E, Vandekerckhove Y.
    Acta Cardiol; 2008 Apr 04; 63(2):181-9. PubMed ID: 18468198
    [Abstract] [Full Text] [Related]

  • 56. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.
    Verma A, Kilicaslan F, Schweikert RA, Tomassoni G, Rossillo A, Marrouche NF, Ozduran V, Wazni OM, Elayi SC, Saenz LC, Minor S, Cummings JE, Burkhardt JD, Hao S, Beheiry S, Tchou PJ, Natale A.
    Circulation; 2005 Jun 21; 111(24):3209-16. PubMed ID: 15956125
    [Abstract] [Full Text] [Related]

  • 57. Epsilon wave in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Wu S, Wang P, Hou Y, Yang P, Xiao Y, Zhan X.
    Pacing Clin Electrophysiol; 2009 Jan 21; 32(1):59-63. PubMed ID: 19140914
    [Abstract] [Full Text] [Related]

  • 58. Prolonged Electromechanical Interval Unmasks Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Subclinical Stage.
    Mast TP, Teske AJ, Te Riele AS, Groeneweg JA, Van Der Heijden JF, Velthuis BK, Loh P, Doevendans PA, Van Veen TA, Dooijes D, De Bakker JM, Hauer RN, Cramer MJ.
    J Cardiovasc Electrophysiol; 2016 Mar 21; 27(3):303-14. PubMed ID: 26585103
    [Abstract] [Full Text] [Related]

  • 59. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H.
    J Am Coll Cardiol; 2004 May 19; 43(10):1843-52. PubMed ID: 15145110
    [Abstract] [Full Text] [Related]

  • 60. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Chung FP, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chao TF, Liao JN, Chiou CW, Chen SA.
    J Cardiol; 2015 Jun 19; 65(6):441-50. PubMed ID: 25818480
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.